Simeox Therapy at Home Versus Standard of Care in NCFB Patients With CMH
NCT: NCT06237348 · COMPLETED
NCT IDNCT06237348
StatusCOMPLETED
Start Date2023-12-01
Completion2024-12-30
SponsorPhysio-Assist (INDUSTRY)
First posted
Last updated
Brief Summary
This pilot RCT will assess benefits of Simeox technology on lung function, respiratory symptoms, health-related quality of life, subjective efficiency, device adherence at home, Patient satisfaction, tolerance, safety, and telecare feasibility.
Frequently Asked Questions
What is Simeox Therapy at Home Versus Standard of Care in NCFB Patients With CMH?
Simeox Therapy at Home Versus Standard of Care in NCFB Patients With CMH is a clinical trial registered under NCT06237348. Current status: COMPLETED.
What is the status of NCT06237348?
The current status of NCT06237348 (Simeox Therapy at Home Versus Standard of Care in NCFB Patients With CMH) is: COMPLETED.
When did Simeox Therapy at Home Versus Standard of Care in NCFB Patients With CMH start?
Simeox Therapy at Home Versus Standard of Care in NCFB Patients With CMH started on 2023-12-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.